Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 5, 2003, Pages 1007-1021

  Furnary, Anthony P ^a,c   Gao, Guangqiang ^a   Grunkemeier, Gary L ^b   Wu, YingXing ^b   Zerr, Kathryn J ^b   Bookin, Stephen O ^b   Floten, H Storm ^a   Starr, Albert ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; INSULIN;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFICACY; FEMALE; GLUCOSE METABOLISM; HEART EJECTION FRACTION; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SURGICAL RISK; UNSTABLE ANGINA PECTORIS;

EID: 0037849854     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.181     Document Type: Article

References (42)

1. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg. 1997;63:903-8.
2. Shroyer AL, Plomondon ME, Grover FL, Edwards FH. The 1996 coronary artery bypass risk model: the Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg. 1999;67:1205-8.
3. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045-52.
4. Harris MI. Classification and diagnostic criteria for diabetes mellitus and other categories of glucose intolerance. Prim Care. 1988;15:205-25.
5. Stephens JW, Krause AH, Peterson CA, Bass JJ, Hartman JE, Salomon NW, et al. The effect of glucose priming solutions in diabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 1988;45:544-7.
6. Salomon NW, Page US, Okies JE, Stephens J, Krause AH, Bigelow JC. Diabetes mellitus and coronary artery bypass. Short-term risk and long-term prognosis. J Thorac Cardiovasc Surg. 1983;85:264-71.
7. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J. 1996;17:1337-44.
8. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-32.
9. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation. 1998;98:2227-34.
10. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Shemin RJ, Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1997;113:354-60.
11. Rao V, Borger MA, Weisel RD, Ivanov J, Christakis GT, Cohen G, et al. Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc Surg. 2000;119:1176-84.
12. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucoseinsulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-50.
13. Randle PJ. Metabolic fuel selection: general integration at the wholebody level. Proc Nutr Soc. 1995;54:317-27.
14. Furnary AP, Zerr KJ, Grunkemeier GL, Heller CA. Hyperglycemia: a predictor of mortality following CABG in diabetics. Circulation. 1999(Suppl);100:I591.
15. O'Connor GT, Birkmeyer JD, Dacey LJ, Quinton HB, Marrin CA, Birkmeyer NJ, et al. Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 1998;66:1323-8.
16. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-61.
17. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons: 2000.
18. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-60.
19. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-86.
20. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-92.
21. Taegtmeyer H. Carbohydrate interconversions and energy production. Circulation. 1985;72(5 Pt 2):IV1-8.
22. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem. 1991;266:8162-70.
23. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem. 1993;268:25836-45.
24. Kantor PF, Dyck JR, Lopaschuk GD. Fatty acid oxidation in the reperfused ischemic heart. Am J Med Sci. 1999;318:3-14.
25. Hasin Y, Barry WH. Myocardial metabolic inhibition and membrane potential, contraction, and potassium uptake. Am J Physiol. 1984;247(2 Pt 2):H322-9.
26. Meyer C, Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol. 1997;80(3A):94A-101A.
27. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici PG. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol. 1993;264:E308-15.
28. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155-8.
29. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest. 1971;50:1386-9.
30. Rao V, Merante F, Weisel RD, Shirai T, Ikonomidis JS, Cohen G, et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg. 1998;116:485-94.
31. Lazar HL. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions. Am J Cardiol. 1997;80(3A):90A-93A.
32. Lazar HL. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg. 1994;9 Suppl:474-8.
33. Liedtke AJ. Lipid burden in ischemic myocardium. J Mol Cell Cardiol. 1988;20 Suppl 2:65-74.
34. Hess ML, Okabe E, Poland J, Warner M, Stewart JR, Greenfield LJ. Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion: a new proposed mechanism by the scavenging of free radicals. J Cardiovasc Pharmacol. 1983;5:35-43.
35. Knuuti MJ, Maki M, Yki-Jarvinen H, Voipio-Pulkki LM, Harkonen R, Haaparanta M, et al. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol. 1995;27:1359-67.
36. Fietsam R Jr, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg. 1991;57:551-7.
37. Rao V, Ivanov J, Weisel RD, Cohen G, Borger MA, Mickle DA. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg. 2001;71:1925-30.
38. Smedira NG, Blackstone EH. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg. 2001;71 Suppl:S60-6.
39. Whitlow PL, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Mantle JA, et al. Enhancement of left ventricular function by glucoseinsulin-potassium infusion in acute myocardial infarction. Am J Cardiol. 1982;49:811-20.
40. Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg. 1995;60:411-6.
41. Ramanathan T, Shirota K, Morita S, Nishimura T, Huang Y, Hunyor SN. Glucose-insulin-potassium solution improves left ventricular mechanics in diabetes. Ann Thorac Surg. 2002;73:582-7.
42. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-67.